Healthcare Providers and Services
Company Overview of Brigham and Women's Hospital
Brigham and Women's Hospital, an academic medical center, operates inpatient and outpatient facilities, clinics, primary care health centers, and diagnostic and treatment technologies and research laboratories. It provides clinical, translational, bench, and population-based research studies, including nurses health studies, physicians health studies, and the women's health initiatives. The company also offers cardiovascular medicine, neurology, neurosurgery, newborn medicine, obstetrics and gynecology, orthopedic surgery, pathology, psychiatry, radiation oncology, radiology, surgery, women’s health, arthritis and rheumatic disorders, orthopedics, pain management, dermatology, emergency medi...
75 Francis Street
Boston, MA 02115
Founded in 1980
Key Executives for Brigham and Women's Hospital
Chief Operating Officer and Executive Vice President
Senior Vice President of Communication and Public Affairs
Compensation as of Fiscal Year 2015.
Brigham and Women's Hospital Key Developments
Transition Therapeutics Ireland Limited Enters into Agreement for Phase 2 Study of TT701 Drug Candidate with Brigham and Women's Hospital
Oct 29 15
Transition Therapeutics Inc. announced that Transition Therapeutics Ireland Limited (TTIL) has entered into an agreement for an investigator-led clinical study of drug candidate, TT701, with Brigham and Women's Hospital (BWH). TTIL will support a Phase 2 study to evaluate selective androgen receptor modulator (SARM) drug candidate TT701 as a therapy to improve the symptoms of androgen deficiency in men with prostate cancer who have undergone a radical prostatectomy procedure. The Phase 2 clinical study is expected to enroll up to 125 subjects and will be performed at selected specialized clinical sites including BWH. The principal investigator for the Phase 2 study will be Dr. Shalender Bhasin, Director of the Research Program in Men's Health: Aging and Metabolism at BWH and an internationally recognized endocrinologist with expertise in testosterone biology and men's aging. The Phase 2 study is scheduled to commence in calendar fourth quarter of 2015.
Evergrande Health Industry Group Limited Enters into Memorandum of Understanding with Brigham and Women's Hospital
Sep 25 15
Evergrande Health Industry Group Limited entered into a memorandum of understanding with Brigham and Women's Hospital. Brigham and Women's Hospital will serve as the strategic partner to the Company as they endeavor to advance the healthcare delivery system in China. Brigham and Women's Hospital will provide the Group with strategic guidance on healthcare-related projects. Specifically, Brigham and Women's Hospital will advise the Group in the areas of healthcare administration, training, hospital design and clinical programs.
Brigham and Women's Hospital Plans to Cut 100 Positions as Costs Rise
Sep 1 15
Brigham and Women's Hospital planned to cut 100 positions to save $10 million as costs rise faster than revenues. The cuts, taking effect over several months, will include both layoffs and leaving vacant positions unfilled. They will apply to all jobs that do not deal in direct patient care. No doctors, nurses, or other staff who work directly with patients will be laid off.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|